Skip to main content

Business: Funding Strategies to Go the Distance

· 16 min read
AI Playbook author

Raising money is like sex, relationships, and money itself: people want to know about it, few talk openly about it, and it can get unnecessarily complicated. It need not. The real work is deciding whether you should raise at all — then building a trajectory that keeps you funded until the company can stand on its own.

Source note: This article synthesises a Harvard Innovation Labs Startup Secrets workshop led by Michael SkokFunding Strategies to Go the Distance — with guest contributions from Maya (Common Angels), Jeffrey Bussgang (Flybridge / Seed to A), Reed Sturtevant (Techstars Boston), Carmichael Roberts, Rich D’Amore, and case study founder Steve Papa (Endeca → Oracle). It is a practitioner summary, not a transcript. Materials live on Startup Secrets / mjskok.com.


First decision: should you raise at all?

Funding follows personal profile and company ambition — not the other way around.

Reason not to raiseWhy it matters
No needIf the business can bootstrap, external capital is optional
Risk aversionTaking others’ money puts them at risk and pressure on you — if you have scruples
Lifestyle businessCash flow that supports life and a durable company can be enough; “lifestyle” is not a synonym for small

SAS Institute is the canonical large lifestyle example: a multi-billion-dollar business built without the classic VC path. Goodnight chose that profile. Capital intensity and personal appetite for the venture path have to match.

Skok’s own first company bootstrapped profitably past ~$20M before VC — and he learned more in that period than almost any other. Bootstrap when you can. Customer money beats investor money.

Also evolving outside the classic ladder: AngelList-style syndication, Kickstarter-style product validation before (or instead of) equity, crowdfunding, grants, and non-equity structures. Treat the landscape as open, not fixed.


The classic capital ladder (and what sits beside it)

Typical equity path:

Friends & family → Angels → Seed → Accelerators → Series A / growth equity / PE → Public markets (or sustainable independence)

Non-dilutive and creative paths matter early:

  • Bootstrap / customer-funded development
  • Strategic partnering
  • Government support
  • Philanthropy and grants (especially not-for-profits)
  • Off-balance-sheet structures

You do not need venture to build something valuable. You do need a clear fit between opportunity size, capital required, and the kind of investor who can go the distance with you.


Funding follows company stages

Stages entrepreneurs actually use (labels vary; order is malleable):

Ideation → Confirmation → Creation → Validation → Repeatability → Scale → Business / financial model → Sustainable / IPO-ready

Handwritten on purpose: you can reorder, parallelise, or compress. The constant is milestones — at each stage, either build great potential or show enough proof to justify the next round. If you have neither, do not raise; close the open questions first.

Startup secret — two great times to raise:

  1. All potential — almost nothing to disprove; a strong pitch can excite people into the opportunity
  2. Clear proof — a vector of data that shows a path to a valuable company

The messy middle — scattered data points, half-working product, unclear model — is when diligence invents its own theories and fundraising gets hard. Life forces multiple raises anyway, so design milestones that repeatedly recreate “potential” or “proof.”

Early stage: confirm the problem before the product

Paper prototypes, customer conversations, and a sharp value proposition beat a polished MVP aimed at nobody. A problem well defined is half solved. Worst early mistake: hurtling into build mode with a lean-startup MVP and no clear who / what problem.

Customer checks (“I’ll pay if you build it”) — or better, customers who co-fund — are the ideal bootstrap. Latent needs (nobody “needed” an iPad five years early) still deserve early validation of the opportunity, not blind faith.

Ask the hard questions of yourself before angels and VCs ask them of you.

Series A crunch: own the next step

Too many seeds, not enough follow-on capital. Spray-and-pray seed is easy for investors (money is cheap relative to your life). If seed does not put you in a position where the next investor can say “yes, more,” you land in the crunch.

Think one round ahead. Seed should buy product (not only vision) and proof that justifies A.

Later rounds

StageTypical proof
B / C / DCustomer validation, references, working GTM, beachheads, defensible segments
LateClear business model; path to leverage and profitability
Public / durable privateFinancial model with high value for capital deployed

Investors watch two curves the whole way: decreasing risk and increasing value. Start with the end in mind — a public-company-grade financial story, or a self-sustaining non-profit entity.

The piece missing from every funding slide: team

IP walks out the door every night. At each stage, how are you building a team that can ship, support customers, create references, and stand alone? Founders who build around their strengths and weaknesses win diligence. Human capital is as real as cash capital.

Counterexample that proves the rule is not rigid: Starent went ~24 months with no revenue, a brutal Series B — and later a ~$2.8B outcome (IPO / Cisco). Principle still holds: show progress, reduce risk, increase value — in a form that fits your business.

Business model earlier than the slide suggests

Audience challenge (correct): model, packaging, pricing, channels, and cash requirements belong in ideation, not only late-stage slides. Red Hat built a multi-billion business less on product invention than on a distinctive model around open source. Technology breakthrough and business-model breakthrough both count.


Capital types that matter early

Angels and angel networks

Usually thousands to a few million; individuals or networks (e.g. Common Angels, Tech Coast Angels). Networks evolved toward group investing and funds because the market got competitive and term sheets needed to stay Series-A-friendly.

Benefit of the right angel: domain expertise — channels, product, real problem definition — that shortcuts years of mistakes. Choose wisely: you interview them as hard as they interview you.

Seed: spray-and-pray vs seed-to-A

TypePatternFounder implication
Spray-and-prayLots of small checks, little mentoring, weak follow-on commitmentMoney arrives; thousand questions follow with no partner
Seed-to-A“Prove X; if you do, we want the A”Clear expectations; still not a guarantee

Jeffrey Bussgang’s fork: Are you raising seed to ride the express to a $20–50M+ venture path — or to buy proof points so you can later choose venture vs a smaller, still excellent business (e.g. $3–5M raised, $100–300M exit)? Apply agile thinking to the business: reduce risk and increase value early enough to keep optionality. Getting off the venture track is hard once you are on it.

Above all: even if someone will write the check, ask whether you want to invest the next 6–8 years of your life. That is the real seed confirmation.

Accelerators (investor-aligned)

Techstars-style programs wear an investor hat (equity, alignment with your success), not a vendor or landlord hat. Small check, short program; real value is mentor density, network, cohort learning, and pattern recognition on investors. Strong fit for first-time founders or domain switchers — if you can get in.

Non-equity and not-for-profit

Philanthropy, grants, government, strategic partnering. Carmichael Roberts’ tip for non-profits: find one highly credible philanthropist who will put in money and shoulder-to-shoulder time, then let them explain why they backed you — not a shotgun of cold asks.

Creative finance can fund solar, medtech stents, and social ventures that classic equity alone would choke. Explore before defaulting to “we need a VC.”

Strategic / corporate investors

Boil it down:

  1. What’s in it for you?
  2. Are priorities aligned?

Corporate agenda is often a hedge / free R&D on a threat. Yours is usually brand, channel, and acceleration. Misalignment = do not take the money.

Startup secret: close the commercial deal first — when you have leverage. Corp-dev is often miles from the sales org that would actually take you to market. A check does not train their field force.


Fit matrix: potential vs capital required

Simplify to one question: huge potential × what capital intensity?

Low capitalHigh capital
Huge potentialBootstrap / stay away from VC if you can (SAS pattern)Classic VC candidate (e.g. capital-intensive medtech with industry-scale upside)
Tiny opportunityMaybe a lifestyle or small private businessAvoid — ton of capital for tiny upside

Clarify time expectations early. Unrealistic growth or spend timelines are where relationships unglue.

If you are a VC candidate: some firms skip seed; some only do early; some only late / mezzanine. Map fit. Time intensity from a partner often beats capital intensity at the start (Acquia: months of model work in the firm’s office before the open-source business was fundable).

What to expect from a VC (decide before you hunt)

Money is the same colour. Differentiate on:

  • Operating experience vs pure investment professional
  • Help building team and board
  • Access / unfair competitive advantage (contacts, channels)
  • Strategic insight depth
  • Capital planning and reserves for follow-on (2008 taught hard lessons when big brands could not support portfolio companies)

Interview them. Good boards ask hard questions that force clarity — not twenty operating ideas that confuse priorities.


Relationships and money: finding signal in noise

VCs see thousands of plans. Most die because there is no trusted signal — not only because of targeting, time, or chemistry. Warm, credible sources filter noise.

Research beyond the website

  • Geography, sector, stage fit
  • Complementary portfolio / space knowledge
  • Which partner has expertise or interest
  • Track record (returns → ability to raise next fund)
  • Reserves and capital planning for follow-on across the company’s life

Then triangulate connection: community, conferences, blogs, intros — so you are not anonymous noise.

There is no one process

Demandware: ~8 days to decision (known space, known founder). Acquia seed: ~6 months of working together before a check. Run your process: check your criteria for fit and whether you want to work with them.

Dating, not dump-trucking

First connection: who / what / why — a hook, not the whole business plan on the phone. Goal of meeting one is meeting two. (Pitch craft: see Perfect Pitch.)

Build momentum with progress points: “Here’s what I’ll do; here’s how it turned out.” Credibility compounds. Avoid the awkward third date of “we met, we pitched, now what?”

You will be incomplete on team, product, value prop, GTM, business model, and/or financials. Stand out in at least one area — preferably unmatched fitness for the problem — rather than a bland 6/10 everywhere.

Diligence is collaborative

Expect blind references, expert under-the-hood reviews, and incomplete-area mapping. Use it as access to people you could not reach alone. Evaluate the VC’s network while they evaluate you.

Term sheets: early vs post-diligence

TimingReality
Early term sheetUseful signal; low certainty until diligence
Post-diligence term sheetMuch higher close probability; mostly legal left

Prefer the second when you need capital with certainty. If you hold an early sheet and like another firm still in diligence: stay transparent, do not sign prematurely, keep options alive. VCs are competitive — pursuit accelerates closings. Multiple like-for-like term sheets beat apples-to-oranges. Limited exclusivity forced early is a relationship smell; mutual fit should not require getting “too pregnant.”

Qualify every meeting: “Was this good? Do you want to move forward?” Meandering past ~a month with unclear seriousness → probability collapses; move on. Opportunity cost is the real expense. Helpful non-investors can still mentor — use common sense.

Best process: diligence is the deal shaping — amount, milestones, partnership — as you go (Rich D’Amore’s style).


How much: need, want, and raise

Three different questions:

1. How much do you need?

Cost to get from current stage to next proof (value up, risk down). Assumptions matter more than spreadsheet polish. North Bridge-style rule of thumb: ~18 months of runway (raise takes ~3 months; you want proof before you are empty). Business-dependent: some need 6 months of sharp milestones; FDA-class paths need far more.

Be a realistic optimist: not “0 → $50M in 3 years on 2% of a billion” fantasy, and not a boring decade crawl VCs will ignore. Plans are wrong; good assumption talk is what gets assessed. Successful outcomes are often later and larger than the model.

2. How much do you want?

Need + fudge factor for market timing and things outside your control.

3. What should you raise?

StrategyProfile
Raise only what you needDilution-sensitive, high risk tolerance, nail milestones
Raise more / earlier cushionRoom to experiment; money “cheap”; accept more dilution

Neither is wrong. Sync the strategy with your investor. Either way: timing is everything. Overestimate adoption speed and underestimate capital → raise from weakness. Never ideal.

Other factors: predictability of the business (transaction vs approval-driven), winner-take-all / beachhead credibility (balance sheet as signal), and valuation — which Skok ranks as least important vs success.

Valuation: think one round ahead

Haggling this round’s pre-money rarely decides your life outcome; owning a sliver of a huge win beats 100% of a dud. Project the vector: this raise → implied next-round metrics (e.g. simple revenue multiple) → are those milestones real? Align with investors on what B (and maybe C) should look like so expectations do not explode later.

Ignore fantasy comps (“Salesforce / Genentech multiples applied to us”). Fun for the bottom drawer; meaningless for decisions.

Always be closing between rounds: cultivate the next investors continuously.

Critical capital form: the option pool

Human capital is the essential raise. Size the option pool to hire the best — agree it up front so you are not renegotiating mid-hire.

What really matters: investor fit × right amount of capital (cash + human) × timing. Terms must clear the bar; they are not the whole game.


Case study: Steve Papa / Endeca — go the distance

Endeca began as better search / interaction with products, became a BI platform for the world’s largest organisations (IBM among customers), and exited as one of Oracle’s largest acquisitions — ~60 days from first serious call to announcement. The fundraising scars earlier in the company formed the speed instinct for that exit.

Bubble start, winter survival

Founded near Harvard (Hamilton Hall dorm → v0.0.0.1 of what Oracle bought). Macro: VC fundraising went from a few billion a year to ~$100B+ in 2000 — easy seeds and As — then collapsed. Endeca got angels in days, a strong Series A, a six-week first enterprise sale in summer 2000… then hunted customer #2 while IT spend had its first year-over-year decline in decades and “e-commerce is dead” became the pendulum story.

Everyone sought capital; existing investors hated leading price-setting internal rounds; discretionary budgets vanished. Painful quote pattern: “I spent $8M last year trying to solve this; you solve it; I have no money.”

Responses that mattered:

  • Value-added angels who opened doors
  • Solved a brutal adjacent problem → expanded vision from e-commerce to platform
  • Built an experienced team as the pendulum swung back to valuing experience
  • Pounded pavement for prospects even without logos

Term sheets, luck, and 9/11

With ~10 weeks of cash: a “bottom feeder” sheet that would have wiped incentives (take it to save jobs, leave soon after). That sheet let insiders price a painful-but-bearable down round. Then Ampersand — late to tech, known to the management team — engaged. Luck: a partner lived next door to an Arrow Electronics executive who was a real prospect and gave proprietary diligence over the fence. Labor Day weekend term sheet vs insider close timing; board chose partnership quality and ethics under stress.

Then 9/11 mid-process, weeks of cash left, force majeure everywhere. Ampersand: nothing about the company changed; partner drove back from Minneapolis; deal closed days later. Pick partners who stand by you in tough times — and check proprietary references on them.

Lessons Papa stressed

  1. Macroeconomics dominate any fundraising “ninja” skill
  2. Fundraising starts before the pitch — team, chips, cultivated relationships (or, in hot markets, five weeks from cold intro)
  3. Get a term sheet; never stop options until the round is done — even a weak sheet creates manage-to outcomes
  4. Multi-period game — fair deals in context; good partners return the favour later
  5. Luck is not optional — cultivate it (prospects, references, presence)
  6. Once you agree, close before the world changes

That last lesson drove the Oracle path in 2011: after 2001 and 2008–09, with thin capitalisation and macro risk (U.S. AAA downgrade, Europe odds), they ignored bankers, called known acquirers, LOI in ~10 days, announced in ~60. Experience said: deal on the table → finish it.

Human capital when bootstrapping talent

Selling co-founders and early hires is selling investors: they invest scarce time. Belief in opportunity + belief in you. You may not get first-round draft picks — build with second/third and stack credibility via advisors who vouch for the market.

Acquisition calculus later is art and science: value created, risk of continuing, investors, and people who invested years. Looking after human capital is looking after the company.


Closing checklist

  1. Decide if you should raise — need, risk profile, lifestyle vs venture scale
  2. Map stages to milestones — potential or proof before each ask
  3. Choose capital type on purpose — angel network, seed-to-A, accelerator, non-dilutive, strategic (commercial first)
  4. Fit the matrix — opportunity size × capital intensity × time
  5. Interview investors — reserves, partner, operating vs pure finance, unfair advantage
  6. Date with momentum — hook first; progress points; stand out incomplete
  7. Prefer post-diligence term sheets; keep competition transparent until like-for-like
  8. Raise need / want deliberately — ~18 months as default thinking; sync strategy with investor
  9. One round ahead on valuation vectors; size the option pool
  10. Always be closing relationships between rounds — and close agreed deals before the world moves

It can be fun when the money lands. Pick your own path; find an embrace with the right partner — preferably not quite Woody Allen’s.

For adjacent Startup Secrets playbooks on this site, see Perfect Pitch, Roadmap to Success, Have You Got What It Takes?, Value Proposition, and Go-to-Market Strategies.

Discussion

Comments

Share feedback or questions about this page. No account required.

Loading comments…